CVS Loratadine Tablets Recalled for Out-of-Specification Assay Results
CVS Pharmacy loratadine tablets are being recalled because they failed potency testing. Consumers should stop using the product and return it to the pharmacy.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as a Class III recall, which indicates the product is unlikely to cause adverse health consequences. The hazard is a potency failure rather than a toxic contamination or physical defect.
Plain-English summary
CVS Pharmacy, Inc. is recalling CVS Pharmacy, Original Prescription Strength, Loratadine Orally Disintegrating Tablets, USP, 10 mg. The recall involves 10-count and 30-count boxes distributed nationwide by CVS Pharmacy, Inc. The product was manufactured by Ohm Laboratories, Inc.
The recall was initiated because the product failed an out-of-specification (OOS) test for assay, which measures the potency of the drug. This means the tablets may not contain the correct amount of the active ingredient.
Consumers who have purchased these specific tablets should stop using them and return them to their pharmacy for a refund or replacement. The recall covers specific batch numbers and expiration dates listed in the official FDA notice.
The recalled product
- Product
- CVS Pharmacy, Original Prescription Strength, LORATADINE ORALLY DISINTEGRATING TABLETS, USP, 10 mg, packaged in a) 10-count tablets per box, Item 876239, UPC 0 50428 61152 4, and b) 30-count tablets per box, Item 367404, UPC 0 50428 11367 7, Distributed by: CVS Pharmacy, Inc. On
- Manufacturer
- Ohm Laboratories, Inc.
- Category
- Drug — Antihistamine
- Hazard
- Affected units
- 291,312
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Batch Numbers: a) 2644273
- 2644265
- Exp 9/30/2016
- 2617891
- 2617892
- 2617893
- Exp 5/31/2016
- 2625093
- 6/30/2016
- 2544488
- 7/31/2016
- 2600125
- 2600126
- 2600127
- Exp 2/29/2016
- 2610783
- Exp 4/30/2016 b) 2600128
- 2544487
- Exp 7/31/2016
- 2644272
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 21 recalled by Ohm Laboratories, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 21 products in this recall →Related recalls
Same manufacturer · Ohm Laboratories, Inc.
See all →- ModerateOhm Allergy Relief Loratadine Recalled for Out-of-Specification Assay
FDA (Drugs) · 2015-10-21
- ModerateQC Quality Choice Loratadine Tablets Recalled for Out-of-Specification Assay
FDA (Drugs) · 2015-10-21
- ModerateOhm Laboratories Recalls Loratadine Tablets Due to Potency Issues
FDA (Drugs) · 2015-10-21
- ModerateOhm Laboratories Recalls Loratadine Tablets Due to Out-of-Specification Assay
FDA (Drugs) · 2015-10-21
- ModerateOhm Recalls HEB Loratadine Tablets Due to Out-of-Specification Assay
FDA (Drugs) · 2015-10-21
Same hazard · potency failure
See all →- Moderateglo Skin Beauty Remedy Gel recalled as a subpotent hydrocortisone product
FDA (Drugs) · 2026-04-22
- ModerateRhonda Allison calming skin gel recalled as a subpotent hydrocortisone product
FDA (Drugs) · 2026-04-22
- ModerateAvantor magnesium chloride active pharmaceutical ingredient recalled as subpotent
FDA (Drugs) · 2026-04-22
- ModerateSkin Rehab calming hydrocortisone balm recalled as a subpotent drug
FDA (Drugs) · 2026-04-22
- HighTeva isotretinoin 40 mg capsules recalled as superpotent and subpotent
FDA (Drugs) · 2026-04-15